Efficacy and safety of radiotherapy combined with atezolizumab plus bevacizumab in treating hepatocellular carcinoma with portal vein tumour thrombus: a study protocol

INTRODUCTION: Vascular invasion and metastasis are poor prognostic factors in patients with hepatocellular carcinoma (HCC). The efficacy of available therapeutic regimens for unresectable HCC is not satisfactory in HCC with portal vein tumour thrombosis (PVTT). Therefore, this open-label, single-arm...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Kang, Yu, Hong-Ming, Xiang, Yan-Jun, Cheng, Yu-Qiang, Ni, Qian-Zhi, Guo, Wei-Xing, Shi, Jie, Feng, Shuang, Zhai, Jian, Cheng, Shu-Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756192/
https://www.ncbi.nlm.nih.gov/pubmed/36521893
http://dx.doi.org/10.1136/bmjopen-2022-064688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756192/
https://www.ncbi.nlm.nih.gov/pubmed/36521893
http://dx.doi.org/10.1136/bmjopen-2022-064688

Ejemplares similares